R Swamy Venuturupalli, MD
Rheumatology · Beverly Hills, CANPI 1063437648
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,551 of the $13,745 with a category attached, or 62.2%. 27 manufacturers reported payments, led by Pfizer at 42.2% of the total. Reporting peaked in 2022 at $6,436 and has fallen 67.8% since, to $2,072 in 2025.
Across 375 payments — averaging $36.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$6K
- AbbVie$2K
- Amgen$2K
- Novartis$2K
- Johnson & Johnson$455
- Radius Health, Inc.$226
- plus $1K from 21 others
Across 167 payments — averaging $5543.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Navidea Biopharmaceuticals, Inc.$208K
- Pfizer$161K
- Argenx US, Inc.$138K
- Novartis$107K
- Mallinckrodt Hospital Products Inc.$85K
- E.r. Squibb & Sons, L.L.C.$83K
- plus $143K from 4 others
What the payments were for
- Speaking & faculty fees$5,00036%
- Food & beverage$8,55162%
- Education$1941%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 44 | $5,799 |
| AbbVie | 101 | $2,307 |
| Amgen(2 entities) | 85 | $2,196 |
| Novartis | 73 | $1,607 |
| Johnson & Johnson(2 entities) | 17 | $455 |
| Radius Health, Inc. | 9 | $226 |
| UCB, Inc. | 5 | $164 |
| GSK | 7 | $130 |
| ANI Pharmaceuticals, Inc. | 3 | $99 |
| E.r. Squibb & Sons, L.L.C. | 5 | $97 |
| Gilead | 1 | $88 |
| Genentech USA, Inc. | 4 | $84 |
| Mallinckrodt Hospital Products Inc. | 3 | $78 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $51 |
| AstraZeneca(2 entities) | 2 | $42 |
| Avanos Medical | 2 | $41 |
| Boehringer Ingelheim | 2 | $41 |
| Sobi, Inc | 1 | $33 |
| Fidia Pharma USA Inc. | 1 | $33 |
| Zimmer Biomet | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Zyla Life Sciences, Inc. | 1 | $20 |
| Medexus Pharma, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Alvogen Inc | 1 | $19 |
| Celltrion USA Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,745 in reported general payments places this provider in the 75th percentile of 808 rheumatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammakedImmune Globul G/Gly/Iga Avg 46 | 24 | $69,572 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 20 | $32,817 |
| Mycophenolate Mofetil | 11 | $1,650 |
| Hydroxychloroquine Sulfate | 23 | $905 |
| MethotrexateMethotrexate Sodium | 25 | $376 |
| Leucovorin Calcium | 12 | $373 |
| Prednisone | 50 | $364 |
| Duloxetine Hcl | 17 | $346 |
| Ibandronate Sodium | 13 | $288 |
| Tramadol Hcl | 21 | $207 |
| Methylprednisolone | 15 | $119 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Beverly Hills
- Daniel WallaceBeverly Hills$309K
- Christine LeeBeverly Hills$304K
- Stuart SilvermanBeverly Hills$301K
- Sudhakar TumuluriSan Francisco$2.8M
- Ara DikranianSan Diego$2.2M
- Orrin TroumSanta Monica$1.8M
- Robin DoreTustin$1.5M
- Samy MetyasCovina$1.3M
- Rhonda LambertSan Mateo$1.1M
- William ShielMission Viejo$924K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.